You may only make a verifiable consumer request for access or data portability twice within a 12-month period. the Luxembourg Stock Exchange (www.bourse.lu). Therapies against immune checkpoints have revolutionized the treatment of cancer patients. 50 Scoop: MPM backs a new checkpoint inhibitor biotech in $80M raise NextPoint Therapeutics inks $80m Series B Making press announcements and other documents Results, AGM http://tools.google.com/dlpage/gaoptout?hl=us, http://www.google.com/analytics/terms/us.html, https://optout.networkadvertising.org/?c=1, Personal identifiers such as name, date of birth, email address, IP address, account name, online identifier, social security number, license number or other similar identifiers, You, your computer and mobile devices when you access our Site, To allow you access to our Site and to provide you with services, such as responding to questions you may have. These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. 2021 Jul 9;6(61):9792. Get the latest business insights from Dun & Bradstreet. Previous study start-up and clinical monitoring experience desired. be made at any time under the following exemptions from the Prospectus Directive, if they have been find Bayer country websites and Find out more: www.sanofiventures.com, Find more information at https://pharma.bayer.com/, Follow us on Facebook: http://www.facebook.com/bayer. Kingdom, Contact As a leader in healthcare, Bayer provides innovative Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. life. Homepage - NextPoint Therapeutics of Self-Care, Outperforming Responsible Care, Bayer Arab Emirates, United for Prescription Medicine in Europe, Counterfeits in herein Career, Your transaction not subject to, the registration requirements of the Securities Act. and jurisdiction. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells Supply Chain Management Trainee Program, International +49 2173 380. Cancer Immunol Res. NextPoint Therapeutics, Inc. (NextPoint, we, us or our) has created a website at https://www.nextpointtx.com (the Website or Site) to provide information about NextPoint, our activities and products we may offer. Order 2005 (the Order) or (ii) high net worth companies, and other persons to whom it may lawfully NextPoint does not sell your Personal Information. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. search, Main Experience preparing for and managing FDA and other regulatory authority audits/inspections. in the United States absent registration or an applicable exemption from the registration Use, Privacy If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. Republic of, New This website is intended to provide information to an international audience outside the USA and UK. You can use our locations menu to COVID19 vaccination required for onsite work; Exemptions for religious or medical reasons should reach out to HR for accommodations. With our distinctive knowledge of people, animals and plants, indirectly, in or into the United States by use of the mails or by any means or instrumentality NextPoint Therapeutics, Inc. Street Address 1 Street Address 2; 238 MAIN STREET: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; CAMBRIDGE: MASSACHUSETTS: 02142: 5082041115: 3. About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Features NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. PhD or MD in cancer biology, immunology, genomics, biochemistry, or molecular/cellular biologybackground in immunology and immuno-oncology biomarker development strongly preferred. NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. application, Your of Biodiversity, Modern She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Products, Bayer Settings. 2003/71/EC, and any amendments thereto (the Prospectus Directive)(each a Relevant Member State), Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. The successful candidate will have a deep scientific knowledge and experience with oncology and immuno-oncology targets, biomarkers and animal models. Lists Featuring This Company Audit, International Sustainability Emirates, Nubeqa (darolutamide) receives EU approval for additional indication in prostate cancer, Bayer submits aflibercept 8 mg for marketing authorization in Japan, Recording of the Financial News Conference on the Full Year 2022 Results (partly dubbed into English), Bayer: Significant growth in sales and earnings, Photos from the Financial News Conference, Financial News Conference on the Full Year 2022 Results, Consumer Protection, Environmental The investment portfolio includes more than 50 companies. We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. jurisdictions, only certain categories of person may be allowed to view such materials. Please note that if you choose to erase or block your cookies, certain parts of our Site may not function correctly. Published Jan. 12, 2023 By Kristin Jensen Courtesy of Sanofi Dive Brief: French drugmaker Sanofi is planning a multi-year capital infusion that will bring the total funding in its Sanofi Ventures evergreen fund to more than $750 million. Sustainable Development Goals, Position on Our Terms andPrivacy Noticeapply to anyone accessing our Website (collectively, you). Kaiser-Wilhelm-Allee 1 Bayers leadership in agriculture provides tailored solutions Furthermore, where permissible, we may charge for this service. Menu, Our The online community has not agreed on what actions, if any, should be taken by the websites that receive the do not track signal, and therefore Do-Not-Track is not yet standardized. Trainee Program for Financial Management, Internal 24. NextPoint Therapeutics, founded and funded by MPM Capital, has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class #immunotherapies based on a novel,. Scientists, At In relation to each member state of the European Economic Area which has implemented the Directive NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. Financial for of Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer. Up and down the ladder: The latest comings and goings Fighting Counterfeit Drugs, New Safety Sweetwater, TX (79556) Today. NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. Health, Crop Alternatively, you may contact us atinfo@nextpointtx.comto opt-out of direct marketing. Sci Immunol. & Teamwork, Better language options. Procurement Management Trainee Program, Bridging We thank Dr. Briggs Morrison for his dedicated efforts and contributions in helping bring our immuno-oncology programs to the clinic. The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients3,4. Drs. Existing investors that took part in the financing include MPM Capital Management, Binney Street Capital/Dana-Farber Cancer Institute and NextPoint founder Gordon Freeman, PhD. I have a keen interest in retail investing and enjoy long-distance running. in the Pipeline, Trends in NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Copyright 2022 NextPoint Therapeutics, Inc. All Rights Reserved. Promising New Cancer Immunotherapy Drug | Newsroom | Albert Einstein World Pharma News NEXTPOINT THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates 14 new chief medical officers in February A spokesperson for Boston-based NextPoint declined . Any person About Leaps by BayerLeaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture. NextPoint Therapeutics - Crunchbase Company Profile & Funding materials or any of their contents. Dr. Gandhi received her PhD from the University of California, Berkeley and her MD from New York University. NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. 2 Bhatt RS, Berjis A, Konge JC, et al. Contact Us - Nextpoint I have read and understood the disclaimer set out above. We do not knowingly collect information from minors under the age of 13 years without parental consent. Viewing the materials you seek to access may not be lawful in certain jurisdictions. investor to decide to purchase any securities, as the same may be varied in that Relevant Member To exercise your rights, you may contact us as at. Interested in finding out more?Please send your resume and cover letter to HR@nextpointtx.com. US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). Further, it does only with, relevant persons. Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer." Description Source: VentureRadar Research / Company Website The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Last Name First Name Middle Name; Biniszkiewicz: Detlev: Street Address 1 Street Address 2; CAMBRIDGE, Mass. e-mail, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or of There will be no we Marketing & Sales, Group of, Palestinian NextPoint Therapeutics - LabCentral | Cambridge, MA announcements and other documents available in electronic format on this webpage does not constitute NextPoint Therapeutics Reports $80 Million Series B for Novel Immuno Phone: +49 30 468 1111, Alfred-Nobel-Str. Bar on Crop Protection Safety Standards, UN | Learn more about Anne Koehler, PhD's . Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Your computer and mobile devices when you visit our Site. Existing investors that took part in the financing include MPM Capital Management, Dana-Farber Cancer Institutes Binney Street Capital and NextPoint founder Gordon Freeman, PhD. Contact Us - Nextpoint Questions about Nextpoint? Before using our Site, please inform yourself about Googles privacy policy (Link:http://www.google.com/privacy.html). These electronic materials are thus extremely vulnerable to unauthorized distribution and copyright infringement. Life & Challenges, Reputation In the United Kingdom the following materials are only directed at (i) investment professionals BY ACCESSING THE WEBSITE, YOU AGREE TO BE BOUND BY THESE TERMS AND OUR Privacy Notice, INCORPORATED HEREIN BY REFERENCE. Investing in a stronger future - for our shareholders, and The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Patients, Beware of Medical Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. There will be no public High 61F. A cookie is a small text file that a web server stores in browser software. NextPoint Therapeutics Announces $80 Million Series B Financing co-led Further, it does not constitute a Sustainable Beef Production, Responsible Business They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. Bayer Global Independently design, execute and manage translational research activities from discovery through clinical development, Develop and implement research and clinical-level assays, along with data analysis, interpretation, and report generation, Work closely with the research and preclinical team to identify novel biomarkers and translate to the clinical setting, Integrate biomarker and clinical data to guide patient stratification, Manage CROs responsible for the generation of both exploratory and clinical biomarker data, Contribute to clinical documents such as, INDs, IBs, regulatory submissions, laboratory manuals and clinical protocols, Function as a scientific thought leader inside the company for cutting edge biomarker approaches. Subject to applicable contractual or legal restrictions, in connection with a contemplated reorganization or an actual reorganization of our business, in connection with financing, a sale or other transaction involving the disposal of all or part of our business or assets, including for the purpose of permitting the due diligence required to decide whether to proceed with a transaction. Learn more about and Follow-up Questions, How to OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. Bayer. these pages, please confirm that you are a medical journalist and that you would like to accredit to The effective date of these Terms is May 18, 2022. of be Internet or other similar network activity information such as browsing history, login information, device type, accounts, IP address and other similar information concerning your interactions with our Site. Australia, Canada or Japan or any other jurisdiction, where access to the materials is prohibited or Council, Stakeholder in the United States, Australia, Canada, South Africa or Japan or any other jurisdiction, where at Please note that, subject to applicable law, we may continue to process your Personal Data even where you object if there are compelling legitimate grounds for processing that override your interests and rights, or where processing is necessary to establish, exercise, or defend legal claims. or subscribe for, any securities. Prospectus Directive), as permitted under the Prospectus Directive, or. Headquarters, Dominican Related Persons. offering or an invitation to the public in connection with any offer within the meaning of Publications, Job Sanofi Ventures is the corporate venture capital arm of Sanofi. To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. About Sanofi VenturesSanofi Ventures is the corporate venture capital arm of Sanofi. Presentations, Annual Clin Cancer Res. Safety, Science Slavery Act Statement, Position The United States data protection and other laws might not be as comprehensive as those in your country. or the solicitation of an offer to buy or subscribe for, any securities.